FR2940062B1 - Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes - Google Patents

Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Info

Publication number
FR2940062B1
FR2940062B1 FR0807284A FR0807284A FR2940062B1 FR 2940062 B1 FR2940062 B1 FR 2940062B1 FR 0807284 A FR0807284 A FR 0807284A FR 0807284 A FR0807284 A FR 0807284A FR 2940062 B1 FR2940062 B1 FR 2940062B1
Authority
FR
France
Prior art keywords
reagiring
transpirant
treating
agent
compounds capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0807284A
Other languages
English (en)
Other versions
FR2940062A1 (fr
Inventor
Jean Francois Grollier
Henri Samain
Odile Aubrun
Arnaud Laurence Sebillote
Jean Thierry Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0807284A priority Critical patent/FR2940062B1/fr
Publication of FR2940062A1 publication Critical patent/FR2940062A1/fr
Application granted granted Critical
Publication of FR2940062B1 publication Critical patent/FR2940062B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424—Polymers characterized by specific structures/properties characterized by the charge anionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application
FR0807284A 2008-12-19 2008-12-19 Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes Expired - Fee Related FR2940062B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0807284A FR2940062B1 (fr) 2008-12-19 2008-12-19 Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807284A FR2940062B1 (fr) 2008-12-19 2008-12-19 Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Publications (2)

Publication Number Publication Date
FR2940062A1 FR2940062A1 (fr) 2010-06-25
FR2940062B1 true FR2940062B1 (fr) 2011-02-11

Family

ID=41037622

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807284A Expired - Fee Related FR2940062B1 (fr) 2008-12-19 2008-12-19 Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes

Country Status (1)

Country Link
FR (1) FR2940062B1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973236B1 (fr) * 2011-03-31 2013-12-13 Oreal Utilisation d'un dispositif de transfert d'un film cosmetique anti-transpirant applique sur la peau
FR2978032B1 (fr) * 2011-07-22 2013-07-12 Oreal Procede de traitement de la transpiration humaine utilisant un halogenure de cation multivalent et un sel non azote d'anion
FR2978033B1 (fr) * 2011-07-22 2013-07-12 Oreal Procede de traitement de la transpiration humaine utilisant un sel forme a partir d'un sel non halogene de cation multivalent et d'un sel d'anion
WO2013013902A2 (fr) 2011-07-22 2013-01-31 L'oreal Procédé pour le traitement de la transpiration humaine à l'aide d'un sel de cation multivalent et d'un sel d'anion
FR2978036B1 (fr) 2011-07-22 2013-07-19 Oreal Procede de traitement de la transpiration utilisant une composition anhydre comprenant deux reactifs produisant ensemble in situ sur la peau un effet transpirant
FR2978035B1 (fr) 2011-07-22 2015-03-20 Oreal Utilisation comme antitranspirant d'un sel de cation multivalent sans antitranspirant halogene d'aluminium ni de compose susceptible de reagir avec ledit sel pour produire un effet antitranspirant
US9408785B2 (en) 2012-10-15 2016-08-09 L'oreal Hair styling compositions containing aqueous wax dispersions
US10413496B2 (en) 2012-10-15 2019-09-17 L'oreal Aqueous wax dispersions
US10626294B2 (en) 2012-10-15 2020-04-21 L'oreal Aqueous wax dispersions containing volatile solvents
FR3007645A1 (fr) * 2013-06-27 2015-01-02 Oreal Gel emulsionne amidon pemulen
US10561596B2 (en) 2014-04-11 2020-02-18 L'oreal Compositions and dispersions containing particles comprising a polymer
FR3061430B1 (fr) * 2016-12-30 2019-05-24 L'oreal Procede cosmetique pour prevenir et/ou traiter la transpiration et eventuellement les odeurs corporelles.
DE102018206624A1 (de) * 2018-04-27 2019-10-31 Beiersdorf Ag Antitranspirantwirksame Zubereitung umfassend Erdalkalimetallsalze und Carbonsäuren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO149199C (no) * 1977-08-26 1984-03-07 Unilever Nv Antitranspirasjonspreparat.
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
GB9310241D0 (en) * 1993-05-18 1993-06-30 Unilever Plc Cosmetic treatment of substrates
US6695510B1 (en) * 2000-05-31 2004-02-24 Wyeth Multi-composition stick product and a process and system for manufacturing the same
GB0031264D0 (en) * 2000-12-21 2001-01-31 Unilever Plc Antiperspirant products

Also Published As

Publication number Publication date
FR2940062A1 (fr) 2010-06-25

Similar Documents

Publication Publication Date Title
FR2940062B1 (fr) Agent multi composants anti-transpirant comprenant deux composes capables de reagir par interaction physique et procede de traitement de la transpiration humaine en deux etapes
FR2940051B1 (fr) Agent multi composants anti-transpirant comprenant deux composants capables de cooperer et procede de traitement de la transpiration humaine en deux etapes.
BRPI0906527A2 (pt) aparelho para aplicação de bandagens em ferimentos e bandagem médica
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0822162A8 (pt) método para tratamento de doenças das unhas ou leito ungueal e composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal.
BR112012029611A2 (pt) proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico
BR112014029674A2 (pt) composto, composição farmacêutica, método para o tratamento de uma doença, utilização de um composto, conjunto para o tratamento de uma condição mediada pela quinase pim e invenção
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
BRPI0907135A2 (pt) Processos de tratamento de dor crônica
BR112012008282A2 (pt) anticorpos de neutralização anti-nfg humanos como inibidores de curso de ngf seletivos
ZA201505849B (en) Composition of novel carbohydrate drug for treatment of human diseases
LT2303330T (lt) Farmacinės kompozicijos, skirtos parkinsono ligai gydyti
BRPI1006238A2 (pt) método para o tratamento pesticida de plantações e composição
FR2910300B1 (fr) Procede de traitement de la peau par application de composes silicones
BR112013016107A2 (pt) molécula dimérica, método de tratamento de câncer, composição farmacêutica e kit para o diagnóstico de uma patologia ou tumor mediado(a) por upar
FR2934267B1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
BRPI0908719A2 (pt) Metodos de diagnóstico, prevenção e tratamento de doenças de massa óssea
BRPI0923688A2 (pt) compostos e métodos para o tratamento de dor e outras doenças
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
FR2954143B1 (fr) Procede de traitement cosmetique des peaux relachees
BRPI1016208A2 (pt) implante e composição terapêutica para o tratamento de lesões e/ou doenças relacionadas ao sistema musculoesquelético humano e/ou animal
FR2940064B1 (fr) Agent anti-transpirant comprenant des composants capables de former entre eux des liaisons covalentes et procede de traitement de la transpiration humaine en deux etapes
BRPI0923242A2 (pt) uso de racematos de pinocembrina na preparacao de medicamentos para tratamento de acidente vascular cerebral

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20210806